Skip to content

Clinical study on the efficacy and safety of Sacubitril/ Valsartan in patients with acute decompensation of chronic heart failure

Sacubitril / Valsartan improves short term outcomes in patients with acute decompensated heart failure

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046851
Enrollment
Unknown
Registered
2021-05-29
Start date
2017-10-30
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients were hospitalized with the primary diagnosis of acute decompensation of chronic heart failure and had consistent signs and symptoms; 2. NYHA class III/IV; 3. Ejection fraction =400 pg per milliliter or an N-terminal pro-BNP (NT-proBNP) level >= 1600 pg per milliliter, 5. Systolic blood pressure at least 100 mmHg; 6. Estimated glomerular filtration rate (eGFR) >= 30 mL/min per 1.73 m2 (calculated by the Modification of Diet in Renal Disease formula); 7. Potassium concentration = 18 years.

Exclusion criteria

Exclusion criteria: 1. A history of angioedema or other unacceptable side effects of ACEI or ARB; 2. An allergy history of any ingredient of sacubitril/valsartan; 3. Occurrence of acute myocardial infarction in the previous month; 4. Being in perinatal period; 5. Presence of diseases that may seriously affect drug metabolism; 6. The patient's life expectancy less than 6 months.

Design outcomes

Primary

MeasureTime frame
death from cardiovascular causes;

Secondary

MeasureTime frame
the readmission for HF;NYHA grade;6-minute walk distance;

Countries

China

Contacts

Public ContactLi Weimin

Department of Cardiology, The First Affiliated Hospital of Harbin Medical University

liweimin_2009@163.com+86 13804601998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026